Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease

Gastroenterology. 2020 May;158(7):1899-1912. doi: 10.1053/j.gastro.2019.12.054. Epub 2020 Feb 13.

Abstract

Adipose tissue and the liver play significant roles in the regulation of whole-body energy homeostasis, but they have not evolved to cope with the continuous, chronic, nutrient surplus seen in obesity. In this review, we detail how prolonged metabolic stress leads to adipose tissue dysfunction, inflammation, and adipokine release that results in increased lipid flux to the liver. Overall, the upshot of hepatic fat accumulation alongside an insulin-resistant state is that hepatic lipid enzymatic pathways are modulated and overwhelmed, resulting in the selective buildup of toxic lipid species, which worsens the pro-inflammatory and pro-fibrotic shift observed in nonalcoholic steatohepatitis.

Keywords: Adipose Tissue; Fatty Acid Flux; Metabolism; Nonalcoholic Fatty Liver Disease.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adipokines / metabolism
  • Adipose Tissue / metabolism*
  • Adipose Tissue / pathology
  • Adipose Tissue / physiopathology
  • Adiposity*
  • Animals
  • Blood Glucose / metabolism
  • Energy Metabolism*
  • Humans
  • Hyperglycemia / epidemiology
  • Hyperglycemia / metabolism
  • Inflammation Mediators / metabolism
  • Insulin Resistance
  • Liver / metabolism*
  • Liver / pathology
  • Liver / physiopathology
  • Non-alcoholic Fatty Liver Disease / diagnosis
  • Non-alcoholic Fatty Liver Disease / epidemiology
  • Non-alcoholic Fatty Liver Disease / metabolism*
  • Non-alcoholic Fatty Liver Disease / physiopathology
  • Obesity / diagnosis
  • Obesity / epidemiology
  • Obesity / metabolism*
  • Obesity / physiopathology
  • Prognosis
  • Risk Factors
  • Signal Transduction

Substances

  • Adipokines
  • Blood Glucose
  • Inflammation Mediators